Stroke Trial, Recruiting NCT07139314 Sponsor: Capital Medical University Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07139314
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You have been diagnosed with a stroke caused by a large blocked blood vessel in the brain
  • You received emergency treatment to unblock the blood vessel within 24 hours of your stroke starting
  • You have atrial fibrillation (an irregular heart rhythm), confirmed by a heart tracing (ECG), heart monitor during hospital stay, a longer-term heart monitor (such as a Holter monitor), or previous medical records
  • A brain scan (CT or MRI) has shown a specific type of bleeding in or around the area of the stroke (confirm with trial site for exact type)
  • You are being enrolled between 7 days and 4 weeks after your stroke started
  • You or a legally authorised representative are able to give written consent to take part

Who may not be able to join:

  • Your irregular heart rhythm is caused by a treatable or temporary condition, such as a thyroid problem, heart inflammation, recent surgery, or a heart attack
  • You cannot take blood-thinning medications called direct oral anticoagulants (DOACs) — for example, due to an allergy, a specific heart valve condition requiring a different blood thinner, serious kidney or liver problems, certain other medications you take, a low platelet count, or a history of bleeding or clotting disorders
  • You have already taken certain blood-thinning medications too recently before the trial starts
  • You are pregnant, breastfeeding, or have a positive pregnancy test on admission
  • You had major surgery or a serious injury within one month before your stroke
  • You had an active bleeding problem (such as stomach or urinary bleeding) within one month before your stroke
  • You are currently taking two antiplatelet medications together (such as aspirin and clopidogrel), or it is likely you will need to during the trial
  • Your brain scan shows signs of a specific condition affecting small blood vessels called cerebral amyloid angiopathy
  • Your brain scan suggests your symptoms may be caused by something other than a stroke, such as a tumour or brain inflammation
  • You had significant disability or dependence before your stroke (confirm with trial site)
  • You are unlikely to be able to attend or complete a follow-up appointment at 90 days
  • You are currently taking part in another medication clinical trial
  • The trial doctor has any other reason to consider participation unsuitable for you

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 01083198962

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Capital Medical University
Registry
ClinicalTrials.gov
Start date
24 September 2025
Est. completion
31 August 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Composite outcome of recurrent ischemic stroke, symptomatic intracranial hemorrhage, and all-cause death

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov